AHR Stock Analysis: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$48.67
1.51 (3.20%)
▲
5d:
+4.73%
30d:
-2.91%
90d:
+1.25%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AHR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: AHR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.87
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$26.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $48.67, which is considered fair relative to its 30-day fair value range of $46.32 to $49.91. The stock's valuation (Forward PE: 54.8) is in line with its historical norms (60.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This pessimistic expectation contrasts with the company's recent 306.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $49.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: AHR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $58.23 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is approaching resistance at $49.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: AHR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $58.23 (+23.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$46.32 -
$49.91
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 23.5% below Wall St target ($58.23)
Trading Range Analysis
30-Day Trading Range
$46.32 -
$49.91
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$45.69
Resistance Level
$49.17
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
54.84
Wall Street Target
$58.23
(+23.5%)
Revenue Growth (YoY)
20.9%
Earnings Growth (YoY)
306.2%
Profit Margin
4.2%
Valuation Discount vs History
-3.0% cheaper
PE vs Historical
54.8 vs 60.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.0%
(market-implied from PE analysis)
1-Year Target
$45.75
(-3%)
2-Year Target
$44.37
(-6%)
3-Year Target
$43.04
(-9%)
3-Yr Target (if PE normalizes)
(PE: 55→60)
$47.09
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 54.8, Growth: 56.4%)
$159.16
(+238%)
Base:
(SPY PE: 21.8, Growth: 56.4%)
$63.22
(+34%)
Bear:
(PE: 18.5, Growth: 56.4%)
$53.73
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (79x PE), but valuation improves significantly next year (55x PE) as earnings recover.
Trailing PE: 78.85 | Current EPS (TTM): $0.59
Bull Case
$74.59
(+58%)
Analyst growth 45.8%, PE expands to 86.7
Base Case
$67.81
(+44%)
Market implied 45.8%, PE stable at 78.9
Bear Case
$31.63
(-33%)
Severe decline -20.0%, PE contracts to 67.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 54.8 to 60.0
Stabilization Target:
$51.60
(+9.4%)
PE Expansion Potential:
+9.4%
Share & Embed Analysis
Last updated: June 23, 2026 3:59 PM ET
Data refreshes hourly during market hours. Next update: 4:59 PM
Data refreshes hourly during market hours. Next update: 4:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark E Foster
SELL
2000 shares
2026-03-25
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$97 | 60 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$235 | 60 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$21 | 57 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 60 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$45 | 62 BUY |
